Abstract
We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
| Original language | English |
|---|---|
| Pages (from-to) | 329-331 |
| Number of pages | 3 |
| Journal | Urology |
| Volume | 45 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 1 1995 |
Fingerprint
ASJC Scopus subject areas
- Urology
Cite this
Squamous cell carcinoma of the prostate : a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide. / Braslis, Karl G.; David, Richard C.; Nelson, Eustos; Civantos, Francisco; Soloway, Mark S.
In: Urology, Vol. 45, No. 2, 01.01.1995, p. 329-331.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Squamous cell carcinoma of the prostate
T2 - a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide
AU - Braslis, Karl G.
AU - David, Richard C.
AU - Nelson, Eustos
AU - Civantos, Francisco
AU - Soloway, Mark S.
PY - 1995/1/1
Y1 - 1995/1/1
N2 - We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
AB - We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
UR - http://www.scopus.com/inward/record.url?scp=0029245715&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029245715&partnerID=8YFLogxK
U2 - 10.1016/0090-4295(95)80028-X
DO - 10.1016/0090-4295(95)80028-X
M3 - Article
C2 - 7855985
AN - SCOPUS:0029245715
VL - 45
SP - 329
EP - 331
JO - Urology
JF - Urology
SN - 0090-4295
IS - 2
ER -